The Seroprevalence of COVID-19 in Intravenous Drug Users in Comparison to Non-drug Users.

COVID-19 IV drug users Seroprevalence

Journal

Middle East journal of digestive diseases
ISSN: 2008-5230
Titre abrégé: Middle East J Dig Dis
Pays: Iran
ID NLM: 101535395

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 09 08 2020
accepted: 02 12 2020
entrez: 29 10 2021
pubmed: 30 10 2021
medline: 30 10 2021
Statut: ppublish

Résumé

BACKGROUND COVID-19 infection has led to a worldwide pandemic, and new cases are on the rise. Intravenous drug users (IVDU) are presumably at a higher risk of being infected since they have poor personal hygiene, live in groups, and have risky behaviors. The current study aimed to evaluate the seroprevalence of COVID-19 in IVDU in comparison with non-drug users (N-DU). METHODS This cross-sectional study was conducted on 167 IVDU and 134 N-DU. A questionnaire gathering data on demographics, comorbidities, and use of personal protective equipment was administered to all participants. In addition, 5 cc of blood was taken from each individual to test for SARS-CoV-2 specific antibodies (Pishtaz Teb SARS-Cov-2 ELISA kits). RESULTS The mean age of N-DU and IVDU were 38.9 ± 12.9 and 40.38 ± 10.24 years, respectively. COVID-19 seroprevalence in IVDU was 9.7%, and 4.8% in N-DU, but this finding was not statistically significant (

Identifiants

pubmed: 34712441
doi: 10.34172/mejdd.2021.206
pmc: PMC8531943
doi:

Types de publication

Journal Article

Langues

eng

Pagination

67-70

Informations de copyright

© 2021 The Author(s).

Déclaration de conflit d'intérêts

CONFLICT OF INTEREST The authors declare no conflict of interest related to this work.

Références

Subst Abuse Treat Prev Policy. 2020 Jun 5;15(1):39
pubmed: 32503660
Basic Clin Neurosci. 2020 Mar-Apr;11(2):133-150
pubmed: 32855772
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):671-677
pubmed: 32438331
World Neurosurg. 2020 Aug;140:49-53
pubmed: 32474093
Mol Psychiatry. 2021 Jan;26(1):30-39
pubmed: 32929211
Chest. 1987 Apr;91(4):596-602
pubmed: 3549175
Nutr Metab Cardiovasc Dis. 2020 Jul 24;30(8):1227-1235
pubmed: 32595085
Psychiatry Res. 2020 Jul;289:113096
pubmed: 32405115
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Int J Environ Res Public Health. 2020 Aug 13;17(16):
pubmed: 32823740
Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2597-607
pubmed: 23988582
J Int AIDS Soc. 2020 Jul;23(7):e25583
pubmed: 32697423
Curr Opin HIV AIDS. 2014 Mar;9(2):150-5
pubmed: 24406532
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Subst Abus. 2020;41(3):286-291
pubmed: 32697172
Clin Infect Dis. 2012 Jul;55 Suppl 1:S3-9
pubmed: 22715211
Public Health Rev. 2014;35(2):
pubmed: 28366975
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143

Auteurs

Zahra Mohammadi (Z)

Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Sareh Eghtesad (S)

Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Seyed Mohammad Hashemi-Shahri (SM)

Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.

Seyed Mehdi Tabatabaei (SM)

Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.

Maryam Sharafkhah (M)

Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Hossein Poustchi (H)

Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Classifications MeSH